Revolution in Agatharied Hospital: First Micra pacemaker inserted

Revolution in Agatharied Hospital: First Micra pacemaker inserted

In a significant medical development, Agatharied Hospital has successfully deployed a new Micra pacemaker. This groundbreaking technique is being described as a “milestone” in cardiology and could revolutionize the treatment of patients with heart problems. The compact pacemaker is the size of a vitamin tablet and offers innovative functionalities that put conventional devices in the shade.

The Micra pacemaker, which is considered extremely advanced in specialist circles, was developed by senior physician Dr. Veronika Lingg successfully implanted. The advantage of the Micra system lies in its probeless technology, which allows direct implantation into the right ventricle. This procedure is carried out through a minimally invasive procedure using a puncture in the groin, which avoids major procedures such as those required with traditional pacemakers.

Innovative technology and implantation procedures

The size of the Micra is impressive: With a diameter of just 26 millimeters, this pacemaker is 93 percent smaller than usual models. This means that it is not visible from the outside and can help patients live a more inconspicuous life. The implanted Micra is fixed into the heart wall using tiny titanium arms and generates the necessary electrical impulses directly to the heart, instead of using traditional electrodes that often require surgical intervention.

Another notable aspect is that the Micra's battery lasts up to ten years. If the battery is exhausted, the entire device is not replaced because it is firmly attached to the heart muscle. Instead, a new Micra pacemaker is simply added. Dr. Lingg highlights that this is a significant relief for patients as they do not have to go through the stress of a major surgical procedure.

Limited availability and requirements

Although the technology is now available at Agatharied Hospital, not all patients can take advantage of the Micra pacemaker. Reimbursement by health insurance companies is subject to certain conditions. Only patients with established underlying illnesses who require dialysis or who have had an infection problem with conventional pacemakers can hope for full support. In addition, thorough preliminary examinations, including an ECG and echocardiography, are crucial for selecting suitable patients.

In summary, the introduction of the Micra pacemaker at Agatharied Hospital shows the potential of new technologies in cardiology. The possibility of inserting a pacemaker in a minimally invasive manner and without visible traces could significantly improve the quality of life of many patients. Further information about this innovative development is available here to find.